Dexmedetomidine and Liver Transplantation

Clinical trial NCT03770130 · COMPLETED

Trial details

NCT number: NCT03770130
Sponsor: RenJi Hospital
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Dexmedetomidine, Liver Transplantation, Allograft Function, Survival

Start date: 2019-01-14
Primary completion: 2022-10-31
Enrollment: 330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.